Overview and recent advances in the treatment of neuroblastoma

SB Whittle, V Smith, E Doherty, S Zhao… - Expert review of …, 2017 - Taylor & Francis
Introduction: Children with neuroblastoma have widely divergent outcomes, ranging from
cure in> 90% of patients with low risk disease to< 50% for those with high risk disease …

The Myc oncoprotein as a therapeutic target for human cancer

M Vita, M Henriksson - Seminars in cancer biology, 2006 - Elsevier
Myc expression is deregulated in a wide range of human cancers and is often associated
with aggressive, poorly differentiated tumors. The Myc protein is a transcription factor that …

Antisense oligonucleotides: from design to therapeutic application

JHP Chan, S Lim, WSF Wong - Clinical and experimental …, 2006 - Wiley Online Library
SUMMARY 1 An antisense oligonucleotide (ASO) is a short strand of deoxyribonucleotide
analogue that hybridizes with the complementary mRNA in a sequence‐specific manner via …

Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain

LML Chow, R Endersby, X Zhu, S Rankin, C Qu… - Cancer cell, 2011 - cell.com
Mutations in the PTEN, TP53, and RB1 pathways are obligate events in the pathogenesis of
human glioblastomas. We induced various combinations of deletions in these tumor …

MYCN impact on high-risk neuroblastoma: from diagnosis and prognosis to targeted treatment

D Bartolucci, L Montemurro, S Raieli, S Lampis… - Cancers, 2022 - mdpi.com
Simple Summary Neuroblastoma is one of the most diffuse and the deadliest cancer in
children. While many advances have been made in the last few decades to improve patients' …

Age-related transcriptome changes in Sox2+ supporting cells in the mouse cochlea

C Cheng, Y Wang, L Guo, X Lu, W Zhu… - Stem cell research & …, 2019 - Springer
Background Inner ear supporting cells (SCs) in the neonatal mouse cochlea are a potential
source for hair cell (HC) regeneration, but several studies have shown that the regeneration …

Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective

JM de Bont, RJ Packer, EM Michiels, ML Boer… - Neuro …, 2008 - academic.oup.com
Survival rates of pediatric brain tumor patients have significantly improved over the years
due to developments in diagnostic techniques, neurosurgery, chemotherapy, radiotherapy …

Extracellular matrix rigidity modulates neuroblastoma cell differentiation and N-myc expression

WA Lam, L Cao, V Umesh, AJ Keung, S Sen, S Kumar - Molecular cancer, 2010 - Springer
Neuroblastoma is a pediatric malignancy characterized by tremendous clinical
heterogeneity, in which some tumors are extremely aggressive while others spontaneously …

CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression

X Zhao, D Li, J Pu, H Mei, D Yang, X Xiang, H Qu… - Oncogene, 2016 - nature.com
Previous studies have indicated the important roles of MYCN in tumorigenesis and
progression of neuroblastoma (NB), the most common extracranial solid tumor derived from …

Antitumor activity of sustained N-myc reduction in rhabdomyosarcomas and transcriptional block by antigene therapy

R Tonelli, A McIntyre, C Camerin, ZS Walters… - Clinical Cancer …, 2012 - AACR
Purpose: Rhabdomyosarcomas are a major cause of cancer death in children, described
with MYCN amplification and, in the alveolar subtype, transcription driven by the PAX3 …